Literature DB >> 30448034

Impact of Cognitive Impairment in Patients with Gliomas.

Deborah H Allen, Ashlee R Loughan.   

Abstract

OBJECTIVES: To address the estimated rates of incidence, potential underlying etiologies, and cognitive domains affected from diagnosis and treatment. To describe potential cognitive function interventions. DATA SOURCES: PubMed.
CONCLUSION: Adults with gliomas report that the most distressing, persistent, and greatest negative impact on their lives relates to the cognitive impairment they experience. However, there are several potential interventions that may prevent cognitive decline during treatment or maintain cognitive function long term. IMPLICATIONS FOR NURSING PRACTICE: Awareness of cognitive sequela that adults with gliomas face can lead to early identification, full neurocognitive profiling, and implementation of evidence-based interventions for those experiencing cognitive impairments following cancer treatment.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  chemobrain; cognitive function; cognitive impairment; cognitive intervention; neurocognitive; neuropsychological

Mesh:

Year:  2018        PMID: 30448034     DOI: 10.1016/j.soncn.2018.10.010

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  2 in total

1.  Mitochondrial-associated impairments of temozolomide on neural stem/progenitor cells and hippocampal neurons.

Authors:  Naomi Lomeli; Kaijun Di; Diana C Pearre; Tzu-Feng Chung; Daniela A Bota
Journal:  Mitochondrion       Date:  2020-02-08       Impact factor: 4.160

2.  A functional MRI study of presurgical cognitive deficits in glioma patients.

Authors:  Irena T Schouwenaars; Miek J de Dreu; Geert-Jan M Rutten; Nick F Ramsey; Johan M Jansma
Journal:  Neurooncol Pract       Date:  2020-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.